The global market for Polymyxins was valued at US$ 3022 million in the year 2024 and is projected to reach a revised size of US$ 3909 million by 2031, growing at a CAGR of 3.8% during the forecast period.

Polymyxins Market

Rising Antibiotic Resistance: The emergence of antibiotic-resistant bacteria, including multidrug-resistant Gram-negative pathogens like carbapenem-resistant Enterobacteriaceae (CRE) and Pseudomonas aeruginosa, has increased the use of polymyxins as last-resort treatments.

Limited Treatment Options: Polymyxins are considered one of the few remaining treatment options for infections caused by extensively drug-resistant (XDR) and pandrug-resistant (PDR) Gram-negative bacteria. Their use is often reserved for cases where no other antibiotics are effective.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polymyxins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polymyxins.

The Polymyxins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polymyxins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Polymyxins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Polymyxins Market Report

Report Metric	Details
Report Name	Polymyxins Market
Accounted market size in year	US$ 3022 million
Forecasted market size in 2031	US$ 3909 million
CAGR	3.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injection Polymyxins External Polymyxins
Segment by Application	Intestinal Disease Infection Septicemia Peritonitis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Meiji Seika Pharm, Shengxue Dacheng, Apeloa, Livzon Group, LKPC, Xellia, BIOK, Vetbiochem, Qianjiang Biochemical, VEGA, Huazhong Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polymyxins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Polymyxins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Polymyxins Market growing?

Ans: The Polymyxins Market witnessing a CAGR of 3.8% during the forecast period 2025-2031.

What is the Polymyxins Market size in 2031?

Ans: The Polymyxins Market size in 2031 will be US$ 3909 million.

Who are the main players in the Polymyxins Market report?

Ans: The main players in the Polymyxins Market are Meiji Seika Pharm, Shengxue Dacheng, Apeloa, Livzon Group, LKPC, Xellia, BIOK, Vetbiochem, Qianjiang Biochemical, VEGA, Huazhong Pharmaceutical

What are the Application segmentation covered in the Polymyxins Market report?

Ans: The Applications covered in the Polymyxins Market report are Intestinal Disease, Infection, Septicemia, Peritonitis

What are the Type segmentation covered in the Polymyxins Market report?

Ans: The Types covered in the Polymyxins Market report are Injection Polymyxins, External Polymyxins

1 Polymyxins Market Overview

1.1 Product Definition

1.2 Polymyxins by Type

1.2.1 Global Polymyxins Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injection Polymyxins

1.2.3 External Polymyxins

1.3 Polymyxins by Application

1.3.1 Global Polymyxins Market Value by Application (2024 VS 2031)

1.3.2 Intestinal Disease

1.3.3 Infection

1.3.4 Septicemia

1.3.5 Peritonitis

1.4 Global Polymyxins Market Size Estimates and Forecasts

1.4.1 Global Polymyxins Revenue 2020-2031

1.4.2 Global Polymyxins Sales 2020-2031

1.4.3 Global Polymyxins Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Polymyxins Market Competition by Manufacturers

2.1 Global Polymyxins Sales Market Share by Manufacturers (2020-2025)

2.2 Global Polymyxins Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Polymyxins Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Polymyxins, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Polymyxins, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Polymyxins, Product Type & Application

2.7 Global Key Manufacturers of Polymyxins, Date of Enter into This Industry

2.8 Global Polymyxins Market Competitive Situation and Trends

2.8.1 Global Polymyxins Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Polymyxins Players Market Share by Revenue

2.8.3 Global Polymyxins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Polymyxins Market Scenario by Region

3.1 Global Polymyxins Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Polymyxins Sales by Region: 2020-2031

3.2.1 Global Polymyxins Sales by Region: 2020-2025

3.2.2 Global Polymyxins Sales by Region: 2026-2031

3.3 Global Polymyxins Revenue by Region: 2020-2031

3.3.1 Global Polymyxins Revenue by Region: 2020-2025

3.3.2 Global Polymyxins Revenue by Region: 2026-2031

3.4 North America Polymyxins Market Facts & Figures by Country

3.4.1 North America Polymyxins Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Polymyxins Sales by Country (2020-2031)

3.4.3 North America Polymyxins Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Polymyxins Market Facts & Figures by Country

3.5.1 Europe Polymyxins Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Polymyxins Sales by Country (2020-2031)

3.5.3 Europe Polymyxins Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Polymyxins Market Facts & Figures by Region

3.6.1 Asia Pacific Polymyxins Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Polymyxins Sales by Region (2020-2031)

3.6.3 Asia Pacific Polymyxins Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Polymyxins Market Facts & Figures by Country

3.7.1 Latin America Polymyxins Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Polymyxins Sales by Country (2020-2031)

3.7.3 Latin America Polymyxins Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Polymyxins Market Facts & Figures by Country

3.8.1 Middle East and Africa Polymyxins Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Polymyxins Sales by Country (2020-2031)

3.8.3 Middle East and Africa Polymyxins Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Polymyxins Sales by Type (2020-2031)

4.1.1 Global Polymyxins Sales by Type (2020-2025)

4.1.2 Global Polymyxins Sales by Type (2026-2031)

4.1.3 Global Polymyxins Sales Market Share by Type (2020-2031)

4.2 Global Polymyxins Revenue by Type (2020-2031)

4.2.1 Global Polymyxins Revenue by Type (2020-2025)

4.2.2 Global Polymyxins Revenue by Type (2026-2031)

4.2.3 Global Polymyxins Revenue Market Share by Type (2020-2031)

4.3 Global Polymyxins Price by Type (2020-2031)

5 Segment by Application

5.1 Global Polymyxins Sales by Application (2020-2031)

5.1.1 Global Polymyxins Sales by Application (2020-2025)

5.1.2 Global Polymyxins Sales by Application (2026-2031)

5.1.3 Global Polymyxins Sales Market Share by Application (2020-2031)

5.2 Global Polymyxins Revenue by Application (2020-2031)

5.2.1 Global Polymyxins Revenue by Application (2020-2025)

5.2.2 Global Polymyxins Revenue by Application (2026-2031)

5.2.3 Global Polymyxins Revenue Market Share by Application (2020-2031)

5.3 Global Polymyxins Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Meiji Seika Pharm

6.1.1 Meiji Seika Pharm Company Information

6.1.2 Meiji Seika Pharm Description and Business Overview

6.1.3 Meiji Seika Pharm Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Meiji Seika Pharm Polymyxins Product Portfolio

6.1.5 Meiji Seika Pharm Recent Developments/Updates

6.2 Shengxue Dacheng

6.2.1 Shengxue Dacheng Company Information

6.2.2 Shengxue Dacheng Description and Business Overview

6.2.3 Shengxue Dacheng Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Shengxue Dacheng Polymyxins Product Portfolio

6.2.5 Shengxue Dacheng Recent Developments/Updates

6.3 Apeloa

6.3.1 Apeloa Company Information

6.3.2 Apeloa Description and Business Overview

6.3.3 Apeloa Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Apeloa Polymyxins Product Portfolio

6.3.5 Apeloa Recent Developments/Updates

6.4 Livzon Group

6.4.1 Livzon Group Company Information

6.4.2 Livzon Group Description and Business Overview

6.4.3 Livzon Group Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Livzon Group Polymyxins Product Portfolio

6.4.5 Livzon Group Recent Developments/Updates

6.5 LKPC

6.5.1 LKPC Company Information

6.5.2 LKPC Description and Business Overview

6.5.3 LKPC Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.5.4 LKPC Polymyxins Product Portfolio

6.5.5 LKPC Recent Developments/Updates

6.6 Xellia

6.6.1 Xellia Company Information

6.6.2 Xellia Description and Business Overview

6.6.3 Xellia Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Xellia Polymyxins Product Portfolio

6.6.5 Xellia Recent Developments/Updates

6.7 BIOK

6.7.1 BIOK Company Information

6.7.2 BIOK Description and Business Overview

6.7.3 BIOK Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.7.4 BIOK Polymyxins Product Portfolio

6.7.5 BIOK Recent Developments/Updates

6.8 Vetbiochem

6.8.1 Vetbiochem Company Information

6.8.2 Vetbiochem Description and Business Overview

6.8.3 Vetbiochem Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Vetbiochem Polymyxins Product Portfolio

6.8.5 Vetbiochem Recent Developments/Updates

6.9 Qianjiang Biochemical

6.9.1 Qianjiang Biochemical Company Information

6.9.2 Qianjiang Biochemical Description and Business Overview

6.9.3 Qianjiang Biochemical Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Qianjiang Biochemical Polymyxins Product Portfolio

6.9.5 Qianjiang Biochemical Recent Developments/Updates

6.10 VEGA

6.10.1 VEGA Company Information

6.10.2 VEGA Description and Business Overview

6.10.3 VEGA Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.10.4 VEGA Polymyxins Product Portfolio

6.10.5 VEGA Recent Developments/Updates

6.11 Huazhong Pharmaceutical

6.11.1 Huazhong Pharmaceutical Company Information

6.11.2 Huazhong Pharmaceutical Description and Business Overview

6.11.3 Huazhong Pharmaceutical Polymyxins Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Huazhong Pharmaceutical Polymyxins Product Portfolio

6.11.5 Huazhong Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Polymyxins Industry Chain Analysis

7.2 Polymyxins Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Polymyxins Production Mode & Process Analysis

7.4 Polymyxins Sales and Marketing

7.4.1 Polymyxins Sales Channels

7.4.2 Polymyxins Distributors

7.5 Polymyxins Customer Analysis

8 Polymyxins Market Dynamics

8.1 Polymyxins Industry Trends

8.2 Polymyxins Market Drivers

8.3 Polymyxins Market Challenges

8.4 Polymyxins Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Qianjiang Biochemical

VEGA

Huazhong Pharmaceutical

List of Tables

Table 1. Global Polymyxins Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Polymyxins Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Polymyxins Market Competitive Situation by Manufacturers in 2024

Table 4. Global Polymyxins Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Polymyxins Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Polymyxins Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Polymyxins Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Polymyxins Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Polymyxins, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Polymyxins, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Polymyxins, Product Type & Application

Table 12. Global Key Manufacturers of Polymyxins, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Polymyxins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polymyxins as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Polymyxins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Polymyxins Sales by Region (2020-2025) & (K Units)

Table 18. Global Polymyxins Sales Market Share by Region (2020-2025)

Table 19. Global Polymyxins Sales by Region (2026-2031) & (K Units)

Table 20. Global Polymyxins Sales Market Share by Region (2026-2031)

Table 21. Global Polymyxins Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Polymyxins Revenue Market Share by Region (2020-2025)

Table 23. Global Polymyxins Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Polymyxins Revenue Market Share by Region (2026-2031)

Table 25. North America Polymyxins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Polymyxins Sales by Country (2020-2025) & (K Units)

Table 27. North America Polymyxins Sales by Country (2026-2031) & (K Units)

Table 28. North America Polymyxins Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Polymyxins Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Polymyxins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Polymyxins Sales by Country (2020-2025) & (K Units)

Table 32. Europe Polymyxins Sales by Country (2026-2031) & (K Units)

Table 33. Europe Polymyxins Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Polymyxins Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Polymyxins Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Polymyxins Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Polymyxins Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Polymyxins Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Polymyxins Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Polymyxins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Polymyxins Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Polymyxins Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Polymyxins Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Polymyxins Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Polymyxins Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Polymyxins Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Polymyxins Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Polymyxins Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Polymyxins Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Polymyxins Sales (K Units) by Type (2020-2025)

Table 51. Global Polymyxins Sales (K Units) by Type (2026-2031)

Table 52. Global Polymyxins Sales Market Share by Type (2020-2025)

Table 53. Global Polymyxins Sales Market Share by Type (2026-2031)

Table 54. Global Polymyxins Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Polymyxins Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Polymyxins Revenue Market Share by Type (2020-2025)

Table 57. Global Polymyxins Revenue Market Share by Type (2026-2031)

Table 58. Global Polymyxins Price (USD/Unit) by Type (2020-2025)

Table 59. Global Polymyxins Price (USD/Unit) by Type (2026-2031)

Table 60. Global Polymyxins Sales (K Units) by Application (2020-2025)

Table 61. Global Polymyxins Sales (K Units) by Application (2026-2031)

Table 62. Global Polymyxins Sales Market Share by Application (2020-2025)

Table 63. Global Polymyxins Sales Market Share by Application (2026-2031)

Table 64. Global Polymyxins Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Polymyxins Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Polymyxins Revenue Market Share by Application (2020-2025)

Table 67. Global Polymyxins Revenue Market Share by Application (2026-2031)

Table 68. Global Polymyxins Price (USD/Unit) by Application (2020-2025)

Table 69. Global Polymyxins Price (USD/Unit) by Application (2026-2031)

Table 70. Meiji Seika Pharm Company Information

Table 71. Meiji Seika Pharm Description and Business Overview

Table 72. Meiji Seika Pharm Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Meiji Seika Pharm Polymyxins Product

Table 74. Meiji Seika Pharm Recent Developments/Updates

Table 75. Shengxue Dacheng Company Information

Table 76. Shengxue Dacheng Description and Business Overview

Table 77. Shengxue Dacheng Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Shengxue Dacheng Polymyxins Product

Table 79. Shengxue Dacheng Recent Developments/Updates

Table 80. Apeloa Company Information

Table 81. Apeloa Description and Business Overview

Table 82. Apeloa Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Apeloa Polymyxins Product

Table 84. Apeloa Recent Developments/Updates

Table 85. Livzon Group Company Information

Table 86. Livzon Group Description and Business Overview

Table 87. Livzon Group Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Livzon Group Polymyxins Product

Table 89. Livzon Group Recent Developments/Updates

Table 90. LKPC Company Information

Table 91. LKPC Description and Business Overview

Table 92. LKPC Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. LKPC Polymyxins Product

Table 94. LKPC Recent Developments/Updates

Table 95. Xellia Company Information

Table 96. Xellia Description and Business Overview

Table 97. Xellia Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Xellia Polymyxins Product

Table 99. Xellia Recent Developments/Updates

Table 100. BIOK Company Information

Table 101. BIOK Description and Business Overview

Table 102. BIOK Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. BIOK Polymyxins Product

Table 104. BIOK Recent Developments/Updates

Table 105. Vetbiochem Company Information

Table 106. Vetbiochem Description and Business Overview

Table 107. Vetbiochem Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Vetbiochem Polymyxins Product

Table 109. Vetbiochem Recent Developments/Updates

Table 110. Qianjiang Biochemical Company Information

Table 111. Qianjiang Biochemical Description and Business Overview

Table 112. Qianjiang Biochemical Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Qianjiang Biochemical Polymyxins Product

Table 114. Qianjiang Biochemical Recent Developments/Updates

Table 115. VEGA Company Information

Table 116. VEGA Description and Business Overview

Table 117. VEGA Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. VEGA Polymyxins Product

Table 119. VEGA Recent Developments/Updates

Table 120. Huazhong Pharmaceutical Company Information

Table 121. Huazhong Pharmaceutical Description and Business Overview

Table 122. Huazhong Pharmaceutical Polymyxins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Huazhong Pharmaceutical Polymyxins Product

Table 124. Huazhong Pharmaceutical Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Polymyxins Distributors List

Table 128. Polymyxins Customers List

Table 129. Polymyxins Market Trends

Table 130. Polymyxins Market Drivers

Table 131. Polymyxins Market Challenges

Table 132. Polymyxins Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Polymyxins

Figure 2. Global Polymyxins Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Polymyxins Market Share by Type: 2024 & 2031

Figure 4. Injection Polymyxins Product Picture

Figure 5. External Polymyxins Product Picture

Figure 6. Global Polymyxins Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Polymyxins Market Share by Application: 2024 & 2031

Figure 8. Intestinal Disease

Figure 9. Infection

Figure 10. Septicemia

Figure 11. Peritonitis

Figure 12. Global Polymyxins Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Polymyxins Market Size (2020-2031) & (US$ Million)

Figure 14. Global Polymyxins Sales (2020-2031) & (K Units)

Figure 15. Global Polymyxins Average Price (USD/Unit) & (2020-2031)

Figure 16. Polymyxins Report Years Considered

Figure 17. Polymyxins Sales Share by Manufacturers in 2024

Figure 18. Global Polymyxins Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Polymyxins Players: Market Share by Revenue in Polymyxins in 2024

Figure 20. Polymyxins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Polymyxins Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Polymyxins Sales Market Share by Country (2020-2031)

Figure 23. North America Polymyxins Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Polymyxins Sales Market Share by Country (2020-2031)

Figure 27. Europe Polymyxins Revenue Market Share by Country (2020-2031)

Figure 28. Germany Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Polymyxins Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Polymyxins Revenue Market Share by Region (2020-2031)

Figure 35. China Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Polymyxins Sales Market Share by Country (2020-2031)

Figure 45. Latin America Polymyxins Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Colombia Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Polymyxins Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Polymyxins Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Polymyxins Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Polymyxins by Type (2020-2031)

Figure 56. Global Revenue Market Share of Polymyxins by Type (2020-2031)

Figure 57. Global Polymyxins Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Polymyxins by Application (2020-2031)

Figure 59. Global Revenue Market Share of Polymyxins by Application (2020-2031)

Figure 60. Global Polymyxins Price (USD/Unit) by Application (2020-2031)

Figure 61. Polymyxins Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Polymyxins Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-14Y7505

Global Polymyxins Market Research Report 2025

FEATURED COMPANIES

Polymyxins Market Size

Polymyxins Market

Report Scope

Scope of Polymyxins Market Report

Core Chapters

FAQ for this report

How fast is Polymyxins Market growing?

What is the Polymyxins Market size in 2031?

Who are the main players in the Polymyxins Market report?

What are the Application segmentation covered in the Polymyxins Market report?

What are the Type segmentation covered in the Polymyxins Market report?

FEATURED COMPANIES

RELATED REPORTS